Suchergebnisse - "Emberson, Jonathan"

PubPharm (290)

41

Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry

enthalten in: European heart journal. Quality of care & clinical outcomes | 2022

von Lopes, L. | Losi, M. | Sheikh, N. | +119

42

Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes : collaborative meta-analysis of large placebo-controlled trials

enthalten in: Lancet (London, England) | 2022

von Nuffield Department of Population Health Renal Studies Group | SGLT2 inhibitor Meta-Analysis Cardio-Renal Trialists' Consortium | Baigent, C. | +39

CommentIn: Lancet. 2022 Nov 19;400(10365):1745-1747. - PMID 36351457

43

Human genetics uncovers MAP3K15 as an obesity-independent therapeutic target for diabetes

enthalten in: Science advances | 2022

von Nag, A. | Dhindsa, R. | Mitchell, J. | +26

44

Adiposity and NMR-measured lipid and metabolic biomarkers among 30,000 Mexican adults

enthalten in: Communications medicine | 2022

von Aguilar-Ramirez, D. | Herrington, W. | Alegre-Díaz, J. | +13

45

Educational inequalities and premature mortality : the Cuba Prospective Study

enthalten in: The Lancet. Public health | 2022

von Ross, S. | Armas Rojas, N. | Sawatzky, J. | +18

46

Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial

enthalten in: bioRxiv.org | 2022

von Horby, P. | Mafham, M. | Linsell, L. | +26

47

Rare coding variants inCHRNB2reduce the likelihood of smoking

enthalten in: bioRxiv.org | 2022

von Rajagopal, V. | Watanabe, K. | Mbatchou, J. | +37

48

Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report

enthalten in: bioRxiv.org | 2022

von Horby, P. | Lim, W. | Emberson, J. | +23

49

Experiences of the Data Monitoring Committee for the RECOVERY trial, a large-scale adaptive platform randomised trial of treatments for patients hospitalised with COVID-19

enthalten in: Trials | 2022

von Sandercock, P. | Darbyshire, J. | DeMets, D. | +7

50

Experiences of the Data Monitoring Committee for the RECOVERY trial, a large-scale adaptive platform randomised trial of treatments for patients hospitalised with COVID-19

enthalten in: Trials | 2022

von Sandercock, P. | Darbyshire, J. | DeMets, D. | +7